Financial Ratios

GENNEX LABORATORIES LTD.

NSE : NABSE : 531739ISIN CODE : INE509C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE16.280.02 (+0.12 %)
PREV CLOSE ( ) 16.26
OPEN PRICE ( ) 16.20
BID PRICE (QTY) 16.28 (546)
OFFER PRICE (QTY) 16.35 (388)
VOLUME 58166
TODAY'S LOW / HIGH ( )16.15 16.42
52 WK LOW / HIGH ( ) 5.7521.89
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.260.310.320.150.18
   CEPS(Rs)0.300.360.370.220.24
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)4.453.483.152.832.69
   Tax Rate(%)24.1622.9820.2327.1626.64
Margin Ratios
   Core EBITDA Margin(%)6.428.2410.265.426.71
   EBIT Margin(%)10.159.159.125.516.37
   Pre Tax Margin(%)8.427.807.954.255.05
   PAT Margin (%)6.396.016.343.103.70
   Cash Profit Margin (%)7.437.227.734.775.35
Performance Ratios
   ROA(%)5.556.166.953.404.34
   ROE(%)7.439.3510.665.326.75
   ROCE(%)10.7011.7813.188.3210.49
   Asset Turnover(x)0.871.031.101.101.17
   Sales/Fixed Asset(x)2.262.142.101.992.04
   Working Capital/Sales(x)1.272.843.674.255.11
Efficiency Ratios
   Fixed Capital/Sales(x)0.440.470.480.500.49
   Receivable days51.5053.0539.9650.7663.48
   Inventory Days58.0835.6735.7138.8523.33
   Payable days65.0765.5571.9288.41113.41
Valuation Parameters
   PER(x)21.7423.1611.6912.1016.90
   PCE(x)18.6920.2210.068.2212.27
   Price/Book(x)1.262.171.240.661.16
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.341.590.930.500.73
   EV/Core EBITDA(x)10.8814.367.906.578.48
   EV/EBIT(x)12.0016.269.608.3610.66
   EV/CE(x)0.901.420.940.480.78
   M Cap / Sales1.521.560.830.420.71
Growth Ratio
   Net Sales Growth(%)6.352.627.25-0.3327.47
   Core EBITDA Growth(%)18.15-4.2368.10-12.6355.21
   EBIT Growth(%)21.292.8575.81-13.5874.92
   PAT Growth(%)16.20-2.85117.53-16.41165.71
   EPS Growth(%)-16.78-2.84117.59-16.43165.58
Financial Stability Ratios
   Total Debt/Equity(x)0.030.230.180.140.13
   Current Ratio(x)4.531.951.911.681.68
   Quick Ratio(x)3.591.631.651.321.37
   Interest Cover(x)5.886.807.814.384.81
   Total Debt/Mcap(x)0.020.110.150.210.12

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.